Karmanos Cancer Institute — Farmington Hills, Michigan

Karmanos Cancer Institute is a clinical research site located in Farmington Hills, Michigan, United States.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute has participated in 10 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Unresectable Cholangiocarcinoma, Metastatic Cholangiocarcinoma.

Sponsors: Zenith Epigenetics, Incyte Corporation, Pfizer.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute?

Karmanos Cancer Institute has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute conducted?

Karmanos Cancer Institute has 10 clinical trials on record, with 2 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Unresectable Cholangiocarcinoma, Metastatic Cholangiocarcinoma.

Is Karmanos Cancer Institute accredited by Crixeo Health?

Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.